Nagoya City University, abbreviated to Meishidai, is a public university in Japan. The main campus is located in Mizuho-ku, Nagoya City. Other three campuses are also located in the city. Nagoya City University has been ranked the highest among public universities which is also one of leading universities in Japan.

During the past decade, Nagoya City University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya City University" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Chiba University, Japan" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "HOSEI University, Japan" with 1 trials as a collaborator and "Instituto Mexicano de Seguro Social, Mexico" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Nagoya City University" are "Branch Retinal Vein Occlusion" (1 trials), "Chronic Dizziness" (1 trials), "Depression" (1 trials), "Gastric Cancer" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Nagoya City University" in a lesser frequency.

Most popular intervention types in "Nagoya City University" are "Drug" (3 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACT with VR" (1 trials), "CBT" (1 trials), "EAP" (1 trials), "Intraviteal Ranibizumab 0.5mg" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagoya City University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nagoya City University". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nagoya City University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nagoya City University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".